Women in procedural leadership roles in cardiology: The Women In Local Leadership (WILL) observational study

Coylewright, Megan; Dodge, Shayne E.; Bachour, Kinan; Hossain, Sharmin; Zeitler, Emily P.; Kearing, Stephen; Douglas, Pamela S.; Holmes, David R.; Reddy, Vivek Y.; Nair, Devi G.

doi:10.1016/j.hrthm.2021.12.012

Cited by 5 publications

(10 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The research by Coylewright et al demonstrates clearly that underrepresentation begets under-representation. 4 The under-representation of women in the structural workforce is likely to have a negative impact on medical students, trainees, physicians, cardiologists and patients. 1,[4][5][6]58,59 Optimal patient care is provided by a diverse and gender-balanced physician workforce.…”

Section: Role Models Mentors and Workplace Diversitymentioning

confidence: 99%

“…4 The under-representation of women in the structural workforce is likely to have a negative impact on medical students, trainees, physicians, cardiologists and patients. 1,[4][5][6]58,59 Optimal patient care is provided by a diverse and gender-balanced physician workforce. 5,57,[60][61][62][63][64][65][66][67] Patients are more likely to trust physicians who appear similar to themselves and are more likely to have better outcomes.…”

Section: Role Models Mentors and Workplace Diversitymentioning

confidence: 99%

“…5,56,68 58 If our trainees do not see women in these roles or have the support of women in leadership roles, they are less likely to choose procedural subspecialties or be able to navigate the career barriers they face, therefore access to visible mentors and sponsors is recommended. 4,58 Mentors and peer networks are critical to advise and support trainees through the challenges of training. Mentorship is key for career development and can improve diversity, inclusion and retention in the workplace.…”

Section: Role Models Mentors and Workplace Diversitymentioning

confidence: 99%

“…

Women are under-represented in cardiology workforces. [1][2][3][4] This underrepresentation has an impact at the physician and patient level and has been linked to poor outcomes for women with cardiovascular diseases. 1,5 Available data on transcatheter aortic valve replacement (TAVR) and other structural interventional operators suggest that women account for a very small proportion of proceduralists.

…”

mentioning

confidence: 99%

“…1,5 Available data on transcatheter aortic valve replacement (TAVR) and other structural interventional operators suggest that women account for a very small proportion of proceduralists. [1][2][3][4]6 This under-representation persists despite the Ottawa 2010 consensus recommendations that specialist training should aim to produce a workforce that is broadly representative of the population that it serves. 7 There is a paucity of data globally addressing the representation of women among structural interventional cardiologists, and a lack of clarity as to whether this hypothesised underrepresentation affects recruitment to landmark trials, subsequent guideline recommendations, patient selection for treatment, or outcomes.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Under-representation of Women as Proceduralists and Patients in TAVR and TMVr Procedures: Data, Implications and Proposed Solutions

et al. 2022

Self Cite

View full text Add to dashboard Cite

Women are under-represented among transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVr) operators. This review assesses the representation of women as patients and as proceduralists and trial authors in major structural interventions. Women are under-represented as proceduralists in structural interventions: only 2% of TAVR operators and 1% of TMVr operators are women. Only 1.5% of authors in landmark clinical TAVR and TMVr trials are interventional cardiologists who are women (4/260). Significant under-representation and under-enrolment of women in landmark TAVR trials is evident: the calculated participation-to-prevalence ratio (PPR) is 0.73, and in TMVr trials, the PPR is 0.69. Under-representation of women is also evident in registry data (PPR = 0.84 for TAVR registries and for TMVr registries). In structural interventional cardiology, women are under-represented as proceduralists, trial participants and patients. This under-representation has the potential to affect the recruitment of women to randomised trials, subsequent guideline recommendations, selection for treatment, patient outcomes and sex-specific data analysis.

show abstract